Close Menu

NEW YORK (GenomeWeb) — Cancer Genetics (CGI) said today that it signed a distribution deal for its microarray gene expression Tissue of Origin test in China with GeneCast Biotechnology.

According to Rutherford, New Jersey-based CGI, the test is designed to analyze 2,000 individual tumor genes, covering 15 of the most common tumor types and 90 percent of all solid tumors, in order to help identify a malignancy's origin.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.